We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Antikor

Antikor is developing a new cancer treatment using antibody fragment drug conjugate which penetrates solid tumours to destroy cancer cells. Their new treatment only targets pre-determined cancer cells, so healthy cells are not affected.  Biopharma is predicted to become the core of the pharmaceutical industry after undergoing transformation in the laboratory, technology and operations

 



  • £125,000
    raised of £1,500,000 goal
  • Expired
    15 May 2018
  • 0
    backers
  • 01/03/2001
    incorporated 18 years ago
  • Envestors
    Platform
  • EIS
View on Envestors


Please sign in or register to businessagent.com to comment on this pitch.

Sign In Register
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph